Gujarat Terce Laboratories Ltd.

View in App
28.48 +1.35 ▲5.0%

08 December 2023, 04:01:00 PM
Volume: 3,575

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gujaratterce.com
Market Cap 21.13 Cr.
Enterprise Value(EV) 25.59 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.23 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 7.94 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.59 Calculated using Price: 28.48
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.74 Cr. 7,420,300 Shares
FaceValue 10
About Gujarat Terce Laboratories Ltd.
Gujarat Terce Laboratories is engaged in the manufacturing of tablets, capsules, syrup and injections pertaining to the product group, pharmaceutical formulations and ayurvedic medicines. The company is selling its product in the domestic as well as international market.

Gujarat Terce Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Gujarat Terce Laboratories Ltd. Performance

View details >>
1 Day
+4.98%
1 Week
-0.07%
1 Month
+17.73%
3 Month
+44.64%
6 Month
-5.44%
1 Year
+39.61%
2 Year
+83.62%
5 Year
+179.49%
10 Year
+331.52%

Gujarat Terce Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.83 -6.30 -0.15 2.65 4.07 2.52 -26.85 10.77 -21.71
Return on Capital Employed (%) 3.62 0.88 1.93 3.96 5.38 5.77 -16.40 8.31 -14.81
Return on Assets (%) 0.35 -2.66 -0.06 1.26 2.23 1.33 -11.44 3.58 -6.18

Gujarat Terce Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 11 10 10 10 11 11 8 9 7 6
Non Curr. Liab. 8 8 8 2 2 2 2 5 4 4
Curr. Liab. 8 7 6 7 7 9 12 13 17 14
Minority Int.
Equity & Liab. 26 24 24 19 19 22 22 27 27 24
Non Curr. Assets 10 10 11 10 10 10 10 12 11 11
Curr. Assets 17 15 13 10 9 12 12 15 16 13
Misc. Exp. not W/O
Total Assets 26 24 24 19 19 22 22 27 27 24

Gujarat Terce Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 26 25 25 29 31 38 25 40 47 48
Other Income 0 0 0 0 0 0 1 0 0 0
Total Income 27 25 26 29 31 38 26 40 47 48
Total Expenditure -26 -25 -25 -29 -31 -37 -28 -39 -49 -48
PBIDT 1 0 1 1 1 1 -2 1 -2 0
Interest 0 0 0 0 0 0 0 0 -1 -1
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 1 1
Exceptional Items
PAT 0 -1 0 0 0 0 -3 1 -2 0
Adjusted EPS 0 -1 0 0 1 0 -3 1 -2 0

Gujarat Terce Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 0 5 -1 -2 0 0 0
Cash Fr. Inv. 0 0 0 0 1 0 0 0 -2 1
Cash Fr. Finan. -1 -1 -1 0 -5 0 2 2 2 0
Net Change -1 1 -1 0 0 -1 0 1 -1 1
Cash & Cash Eqvt 1 2 0 1 1 0 0 1 0 2

Gujarat Terce Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 36.22 36.22 36.22 36.22 36.22 36.22 36.45 36.65 36.78
Public 63.78 63.78 63.78 63.78 63.78 63.78 63.55 63.35 63.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Gujarat Terce Laboratories Ltd. Announcements

View details >>
Wed, 08 Nov 2023
Un-Audited Standalone Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2023.
Please find attached herewith Un-Audited Standalone Financial Results of the Company for the quarter and half year ended 30th September 2023.
Wed, 08 Nov 2023
Board Meeting Outcome for Outcome Of Meeting Held On 8Th November 2023.
As required under Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the Un-Audited Standalone Financial Results of the Company for the quarter and half year ended 30th September 2023 together with the Limited Review Reports thereon from the Statutory Auditors M/s. M.A. Shah & CO.
Tue, 31 Oct 2023
Board Meeting Intimation for Consideration Of Un-Audited Financial Results For The Quarter And Half Year Ended On 30Th September 2023.
GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Un-audited Financial Results of the Company for the quarter and half year ended on 30th September 2023.

Gujarat Terce Laboratories Ltd. Technical Scans

View details >>
Fri, 08 Dec 2023
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month

Gujarat Terce Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,444.27 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,508.23 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.51 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.97 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Gujarat Terce Laboratories Ltd. FAQ's

What is Guj. Terce Lab share price?
Can I buy Guj. Terce Lab shares now?
What is the Market Cap of Guj. Terce Lab?
What are the key metrics to analyse Guj. Terce Lab?
What is the 52 Week High and Low of Guj. Terce Lab?
What is the trend of Guj. Terce Lab share price?